Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001396814-24-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-05 | 2024-06-03 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $30.89 | -1,843 | 20.7K | -8% | -$56.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | F | D | 1,843 | $30.89 | 20,685.34 | D | — | — |